Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes

Recruiting now · Not applicable

Conditions studied: Type 1 Diabetes (T1D), Latent Autoimmune Diabetes in Adult (LADA), Pancreatitis

In brief

The challenges of living with type 1 diabetes often stand in the way of getting enough exercise. Continuous blood sugar monitoring has revolutionized type 1 diabetes care but remains underutilized to sustainably support exercise and related behaviors. This remote participation-based research will develop a mobile application that delivers personalized encouragement and data-driven health insights based upon patterns in blood sugar, exercise, mood, and sleep, to assist people with type 1 diabetes in exercising more frequently and confidently. You do not need to live in Connecticut to participate, as there will be no required in-person visits during the study.

Key facts

Study ID

NCT06967701

Run by

Yale University

People needed

60

Starts

2025-07-10

Expected to finish

2027-10-01

Last updated by the study team

2026-07-22

Who can join

Age: 30 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 30-65 years old inclusive
• Diagnosis with type 1 diabetes (T1D) or other insulin deficiency diabetes (latent autoimmune disease of adulthood, diabetes secondary to pancreatitis)
• Less than 1.0 exercise sessions per week
• Smartphone ownership
• English literacy
• Under regular care by a healthcare provider (1+ appointments per year)
• Home Broadband wireless Internet or cell phone network
• Using continuous glucose monitor (CGM) and sharing data with medical record for at least 6 weeks
• Using insulin pump or pen and sharing data with medical record for at least 6 weeks

You may not qualify if…

• Diabetic ketoacidosis not clearly related to pump site failure in past 6 months
• >1 episode of severe hypoglycemia (altered mental and/or physical status requiring assistance from another person for recovery) in past 6 months
• A1c ≥10.0%
• Resting blood pressure >160mmHg systolic or >100 mmHg diastolic.
• Myocardial infarction or angina in past 12 months
• Uncontrolled arrhythmia (e.g., atrial fibrillation with rapid ventricular response, new onset atrial fibrillation, ventricular tachycardia, escape rhythms)
• Congestive heart failure (stage 3 or 4)
• Exercise-induced asthma (not controlled on inhalers)
• Chronic obstructive pulmonary disease (requiring home oxygen)
• Renal failure
• Pregnancy
• Cognitive impairment
• Severe retinopathy or neuropathy.
• Other chronic disease or physical disability that would influence exercise intervention (e.g., recent spinal surgery)

Where it is running

• Yale School of Medicine — New Haven, Connecticut, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.